In Vivo Pharmacodynamic Evaluation of B-Tg(Luc)A549 (mix) Cells Induced Lung Cancer Models (CAT#: STEM-AE-0652-LGZ)

Introduction

Cancer type: Lung cancer<br />Cell line: B-Tg(Luc)A549 (mix)<br />Clone: mix clone<br />Inoculation: i.V.

Principle Applications Procedure Materials Notes Related Products

Principle

By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.

Applications

Lung Cancer

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder

Other recommended products

In Vivo Pharmacodynamic Evaluation of B-hGDF15 Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0444-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCD3E/hCD28 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0366-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hLILRB4 MC38 Cells Induced Tumor Models (CAT#: STEM-AE-0174-LGZ)
In Vivo Pharmacodynamic Evaluation of Xylene Induced Local Inflammation in Mice (CAT#: STEM-AE-0148-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hSIGLEC15 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0184-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hALB/hFcRn Mice (Humanized Mice) (CAT#: STEM-AE-0644-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hTROP2 Mice (Humanized Mice) (CAT#: STEM-AE-0593-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hIL27 Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0425-LGZ)